Literature DB >> 30316201

The copper-zinc superoxide dismutase activity in selected diseases.

Łukasz Lewandowski1, Marta Kepinska1, Halina Milnerowicz1.   

Abstract

Copper-zinc superoxide dismutase (Cu,Zn-SOD) plays a protective role in various types of tissue protecting them from oxidative damage. Alterations in Cu,Zn-SOD (SOD1 and SOD3) activity and its expression have been observed in pathological occurrences most prevalent in modern society, including inflammatory bowel disease, obesity and its implications-diabetes and hypertension, and chronic obstructive pulmonary disease. Moreover, several SOD1 and SOD3 gene polymorphisms have been associated with the risk of developing a particular type of disease, or its exacerbation. This article features recent observations in this topic, aiming to show the importance of proper gene sequence and activity of Cu,Zn-SOD in the aforementioned diseases.
© 2018 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  copper-zinc superoxide dismutase; enzyme activity; single-nucleotide polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30316201     DOI: 10.1111/eci.13036

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  15 in total

Review 1.  All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease.

Authors:  Yi-Yao Liang; Li-Dan Zhang; Xi Luo; Li-Li Wu; Zhao-Wei Chen; Guang-Hao Wei; Kai-Qing Zhang; Ze-An Du; Ren-Zhi Li; Kwok-Fai So; Ang Li
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

2.  Paeonol Attenuates Methotrexate-Induced Cardiac Toxicity in Rats by Inhibiting Oxidative Stress and Suppressing TLR4-Induced NF-κB Inflammatory Pathway.

Authors:  Abdulla Y Al-Taher; Mohamed A Morsy; Rehab A Rifaai; Nagwa M Zenhom; Seham A Abdel-Gaber
Journal:  Mediators Inflamm       Date:  2020-02-10       Impact factor: 4.711

3.  Alterations in Concentration/Activity of Superoxide Dismutases in Context of Obesity and Selected Single Nucleotide Polymorphisms in Genes: SOD1, SOD2, SOD3.

Authors:  Łukasz Lewandowski; Marta Kepinska; Halina Milnerowicz
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

4.  Antioxidants-Related Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Peroxidase (GPX), Glutathione-S-Transferase (GST), and Nitric Oxide Synthase (NOS) Gene Variants Analysis in an Obese Population: A Preliminary Case-Control Study.

Authors:  Amani M T Gusti; Safaa Y Qusti; Eida M Alshammari; Eman A Toraih; Manal S Fawzy
Journal:  Antioxidants (Basel)       Date:  2021-04-13

5.  Superoxide Dismutase 3 Controls the Activation and Differentiation of CD4+T Cells.

Authors:  Gaurav Agrahari; Shyam Kishor Sah; Chul Hwan Bang; Yeong Ho Kim; Tae-Yoon Kim
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 6.  Aberrance of Zinc Metalloenzymes-Induced Human Diseases and Its Potential Mechanisms.

Authors:  Yunqi Cheng; Hongping Chen
Journal:  Nutrients       Date:  2021-12-13       Impact factor: 5.717

7.  Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.

Authors:  Julian Seelig; Raban Arved Heller; Patrick Haubruck; Qian Sun; Jochen Georg Klingenberg; Julian Hackler; Helena Lucia Crowell; Volker Daniel; Arash Moghaddam; Lutz Schomburg; Bahram Biglari
Journal:  Front Neurosci       Date:  2021-05-28       Impact factor: 4.677

8.  Activity of CdTe Quantum-Dot-Tagged Superoxide Dismutase and Its Analysis in Capillary Electrophoresis.

Authors:  Natalia Zaręba; Łukasz Lewandowski; Dominika Kunachowicz; Rene Kizek; Marta Kepinska
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

Review 9.  Neurotoxicity of methamphetamine: Main effects and mechanisms.

Authors:  Subramaniam Jayanthi; Atul P Daiwile; Jean Lud Cadet
Journal:  Exp Neurol       Date:  2021-06-26       Impact factor: 5.620

10.  Zinc supplementation affects favorably the frequency of migraine attacks: a double-blind randomized placebo-controlled clinical trial.

Authors:  Hedieh Ahmadi; Seyedeh Shabnam Mazloumi-Kiapey; Omid Sadeghi; Morteza Nasiri; Fariborz Khorvash; Tayebeh Mottaghi; Gholamreza Askari
Journal:  Nutr J       Date:  2020-09-14       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.